Renal Cell Carcinoma of Variant Histology: Biology and Therapies
Msaouel, Pavlos, Genovese, Giannicola, Tannir, Nizar M
Published in Hematology/oncology clinics of North America (01.10.2023)
Published in Hematology/oncology clinics of North America (01.10.2023)
Get more information
Journal Article
Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial
Choueiri, Toni K, Dr, Escudier, Bernard, MD, Powles, Thomas, Prof, Tannir, Nizar M, Prof, Mainwaring, Paul N, MD, Rini, Brian I, Prof, Hammers, Hans J, MD, Donskov, Frede, MD, Roth, Bruce J, Prof, Peltola, Katriina, MD, Lee, Jae Lyun, Prof, Heng, Daniel Y C, MD, Schmidinger, Manuela, Prof, Agarwal, Neeraj, MD, Sternberg, Cora N, Prof, McDermott, David F, MD, Aftab, Dana T, PhD, Hessel, Colin, MS, Scheffold, Christian, MD, Schwab, Gisela, MD, Hutson, Thomas E, Prof, Pal, Sumanta, MD, Motzer, Robert J, Prof
Published in The lancet oncology (01.07.2016)
Published in The lancet oncology (01.07.2016)
Get full text
Journal Article
Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma
Choueiri, Toni K, Escudier, Bernard, Powles, Thomas, Mainwaring, Paul N, Rini, Brian I, Donskov, Frede, Hammers, Hans, Hutson, Thomas E, Lee, Jae-Lyun, Peltola, Katriina, Roth, Bruce J, Bjarnason, Georg A, Géczi, Lajos, Keam, Bhumsuk, Maroto, Pablo, Heng, Daniel Y.C, Schmidinger, Manuela, Kantoff, Philip W, Borgman-Hagey, Anne, Hessel, Colin, Scheffold, Christian, Schwab, Gisela M, Tannir, Nizar M, Motzer, Robert J
Published in The New England journal of medicine (05.11.2015)
Published in The New England journal of medicine (05.11.2015)
Get full text
Journal Article
A Model Linking Sickle Cell Hemoglobinopathies and SMARCB1 Loss in Renal Medullary Carcinoma
Msaouel, Pavlos, Tannir, Nizar M, Walker, Cheryl Lyn
Published in Clinical cancer research (01.05.2018)
Published in Clinical cancer research (01.05.2018)
Get full text
Journal Article
Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non–Clear Cell Renal Cell Carcinoma (ESPN): A Randomized Multicenter Phase 2 Trial
Tannir, Nizar M, Jonasch, Eric, Albiges, Laurence, Altinmakas, Emre, Ng, Chaan S, Matin, Surena F, Wang, Xuemei, Qiao, Wei, Dubauskas Lim, Zita, Tamboli, Pheroze, Rao, Priya, Sircar, Kanishka, Karam, Jose A, McDermott, David F, Wood, Christopher G, Choueiri, Toni K
Published in European urology (01.05.2016)
Published in European urology (01.05.2016)
Get full text
Journal Article
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
Motzer, Robert J, Tannir, Nizar M, McDermott, David F, Arén Frontera, Osvaldo, Melichar, Bohuslav, Choueiri, Toni K, Plimack, Elizabeth R, Barthélémy, Philippe, Porta, Camillo, George, Saby, Powles, Thomas, Donskov, Frede, Neiman, Victoria, Kollmannsberger, Christian K, Salman, Pamela, Gurney, Howard, Hawkins, Robert, Ravaud, Alain, Grimm, Marc-Oliver, Bracarda, Sergio, Barrios, Carlos H, Tomita, Yoshihiko, Castellano, Daniel, Rini, Brian I, Chen, Allen C, Mekan, Sabeen, McHenry, M. Brent, Wind-Rotolo, Megan, Doan, Justin, Sharma, Padmanee, Hammers, Hans J, Escudier, Bernard
Published in The New England journal of medicine (05.04.2018)
Published in The New England journal of medicine (05.04.2018)
Get full text
Journal Article
Comprehensive integrative profiling of upper tract urothelial carcinomas
Su, Xiaoping, Lu, Xiaofan, Bazai, Sehrish Khan, Compérat, Eva, Mouawad, Roger, Yao, Hui, Rouprêt, Morgan, Spano, Jean-Philippe, Khayat, David, Davidson, Irwin, Tannir, Nizar N, Yan, Fangrong, Malouf, Gabriel G
Published in Genome Biology (04.01.2021)
Published in Genome Biology (04.01.2021)
Get full text
Journal Article
PBRM1 loss defines a nonimmunogenic tumor phenotype associated with checkpoint inhibitor resistance in renal carcinoma
Liu, Xian-De, Kong, Wen, Peterson, Christine B., McGrail, Daniel J., Hoang, Anh, Zhang, Xuesong, Lam, Truong, Pilie, Patrick G., Zhu, Haifeng, Beckermann, Kathryn E., Haake, Scott M., Isgandrova, Sevinj, Martinez-Moczygemba, Margarita, Sahni, Nidhi, Tannir, Nizar M., Lin, Shiaw-Yih, Rathmell, W. Kimryn, Jonasch, Eric
Published in Nature communications (01.05.2020)
Published in Nature communications (01.05.2020)
Get full text
Journal Article
Conditional survival and long‐term efficacy with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma
Motzer, Robert J., McDermott, David F., Escudier, Bernard, Burotto, Mauricio, Choueiri, Toni K., Hammers, Hans J., Barthélémy, Philippe, Plimack, Elizabeth R., Porta, Camillo, George, Saby, Powles, Thomas, Donskov, Frede, Gurney, Howard, Kollmannsberger, Christian K., Grimm, Marc‐Oliver, Barrios, Carlos, Tomita, Yoshihiko, Castellano, Daniel, Grünwald, Viktor, Rini, Brian I., McHenry, M. Brent, Lee, Chung‐Wei, McCarthy, Jennifer, Ejzykowicz, Flavia, Tannir, Nizar M.
Published in Cancer (01.06.2022)
Published in Cancer (01.06.2022)
Get full text
Journal Article
Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial
Motzer, Robert J, Rini, Brian I, McDermott, David F, Arén Frontera, Osvaldo, Hammers, Hans J, Carducci, Michael A, Salman, Pamela, Escudier, Bernard, Beuselinck, Benoit, Amin, Asim, Porta, Camillo, George, Saby, Neiman, Victoria, Bracarda, Sergio, Tykodi, Scott S, Barthélémy, Philippe, Leibowitz-Amit, Raya, Plimack, Elizabeth R, Oosting, Sjoukje F, Redman, Bruce, Melichar, Bohuslav, Powles, Thomas, Nathan, Paul, Oudard, Stéphane, Pook, David, Choueiri, Toni K, Donskov, Frede, Grimm, Marc-Oliver, Gurney, Howard, Heng, Daniel Y C, Kollmannsberger, Christian K, Harrison, Michael R, Tomita, Yoshihiko, Duran, Ignacio, Grünwald, Viktor, McHenry, M Brent, Mekan, Sabeen, Tannir, Nizar M
Published in The lancet oncology (01.10.2019)
Published in The lancet oncology (01.10.2019)
Get full text
Journal Article
Definitive radiotherapy in lieu of systemic therapy for oligometastatic renal cell carcinoma: a single-arm, single-centre, feasibility, phase 2 trial
Tang, Chad, Msaouel, Pavlos, Hara, Kieko, Choi, Haesun, Le, Venus, Shah, Amishi Y, Wang, Jennifer, Jonasch, Eric, Choi, Seungtaek, Nguyen, Quynh-nhu, Das, Prajnan, Prajapati, Surendra, Yu, Zhiqian, Khan, Khaja, Powell, Steven, Murthy, Ravi, Sircar, Kanishka, Tannir, Nizar M
Published in The lancet oncology (01.12.2021)
Published in The lancet oncology (01.12.2021)
Get full text
Journal Article
Second‐Line Treatment Landscape for Renal Cell Carcinoma: A Comprehensive Review
Tannir, Nizar M., Pal, Sumanta K., Atkins, Michael B.
Published in The oncologist (Dayton, Ohio) (01.05.2018)
Published in The oncologist (Dayton, Ohio) (01.05.2018)
Get full text
Journal Article
Efficacy of Nivolumab plus Ipilimumab According to Number of IMDC Risk Factors in CheckMate 214
Escudier, Bernard, Motzer, Robert J., Tannir, Nizar M., Porta, Camillo, Tomita, Yoshihiko, Maurer, Matthew A., McHenry, M. Brent, Rini, Brian I.
Published in European urology (01.04.2020)
Published in European urology (01.04.2020)
Get full text
Journal Article
Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 4-year follow-up of the phase III CheckMate 214 trial
Albiges, Laurence, Tannir, Nizar M, Burotto, Mauricio, McDermott, David, Plimack, Elizabeth R, Barthélémy, Philippe, Porta, Camillo, Powles, Thomas, Donskov, Frede, George, Saby, Kollmannsberger, Christian K, Gurney, Howard, Grimm, Marc-Oliver, Tomita, Yoshihiko, Castellano, Daniel, Rini, Brian I, Choueiri, Toni K, Saggi, Shruti Shally, McHenry, M Brent, Motzer, Robert J
Published in ESMO open (27.11.2020)
Published in ESMO open (27.11.2020)
Get full text
Journal Article
Efficacy and Safety of Nivolumab Plus Ipilimumab versus Sunitinib in First-line Treatment of Patients with Advanced Sarcomatoid Renal Cell Carcinoma
Tannir, Nizar M, Signoretti, Sabina, Choueiri, Toni K, McDermott, David F, Motzer, Robert J, Flaifel, Abdallah, Pignon, Jean-Christophe, Ficial, Miriam, Frontera, Osvaldo Arén, George, Saby, Powles, Thomas, Donskov, Frede, Harrison, Michael R, Barthélémy, Philippe, Tykodi, Scott S, Kocsis, Judit, Ravaud, Alain, Rodriguez-Cid, Jeronimo R, Pal, Sumanta K, Murad, Andre M, Ishii, Yuko, Saggi, Shruti Shally, McHenry, M Brent, Rini, Brian I
Published in Clinical cancer research (01.01.2021)
Published in Clinical cancer research (01.01.2021)
Get full text
Journal Article
A First-in-Human Study and Biomarker Analysis of NKTR-214, a Novel IL2Rβγ-Biased Cytokine, in Patients with Advanced or Metastatic Solid Tumors
Bentebibel, Salah-Eddine, Hurwitz, Michael E, Bernatchez, Chantale, Haymaker, Cara, Hudgens, Courtney W, Kluger, Harriet M, Tetzlaff, Michael T, Tagliaferri, Mary A, Zalevsky, Jonathan, Hoch, Ute, Fanton, Christie, Aung, Sandra, Hwu, Patrick, Curti, Brendan D, Tannir, Nizar M, Sznol, Mario, Diab, Adi
Published in Cancer discovery (01.06.2019)
Published in Cancer discovery (01.06.2019)
Get full text
Journal Article
Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long‐term follow‐up of the randomized, open‐label, phase 3 CheckMate 025 trial
Motzer, Robert J., Escudier, Bernard, George, Saby, Hammers, Hans J., Srinivas, Sandhya, Tykodi, Scott S., Sosman, Jeffrey A., Plimack, Elizabeth R., Procopio, Giuseppe, McDermott, David F., Castellano, Daniel, Choueiri, Toni K., Donskov, Frede, Gurney, Howard, Oudard, Stéphane, Richardet, Martin, Peltola, Katriina, Alva, Ajjai S., Carducci, Michael, Wagstaff, John, Chevreau, Christine, Fukasawa, Satoshi, Tomita, Yoshihiko, Gauler, Thomas C., Kollmannsberger, Christian K., Schutz, Fabio A., Larkin, James, Cella, David, McHenry, M. Brent, Saggi, Shruti Shally, Tannir, Nizar M.
Published in Cancer (15.09.2020)
Published in Cancer (15.09.2020)
Get full text
Journal Article
Bempegaldesleukin (NKTR-214) plus Nivolumab in Patients with Advanced Solid Tumors: Phase I Dose-Escalation Study of Safety, Efficacy, and Immune Activation (PIVOT-02)
Diab, Adi, Tannir, Nizar M, Bentebibel, Salah-Eddine, Hwu, Patrick, Papadimitrakopoulou, Vassiliki, Haymaker, Cara, Kluger, Harriet M, Gettinger, Scott N, Sznol, Mario, Tykodi, Scott S, Curti, Brendan D, Tagliaferri, Mary A, Zalevsky, Jonathan, Hannah, Alison L, Hoch, Ute, Aung, Sandra, Fanton, Christie, Rizwan, Ahsan, Iacucci, Ernesto, Liao, Yijie, Bernatchez, Chantale, Hurwitz, Michael E, Cho, Daniel C
Published in Cancer discovery (01.08.2020)
Published in Cancer discovery (01.08.2020)
Get full text
Journal Article